Clinical Study by Salem Pain Clinic, Surrey, Canada, Shows That Facial Topical Cream Enhances Facemask Tolerability and Compliance During the COVID-19 Pandemic
Retrieved on:
Tuesday, November 1, 2022
SURREY, British Columbia, Nov. 01, 2022 (GLOBE NEWSWIRE) -- A clinical research study has shown that facial topical cream promotes facemask tolerability and compliance during the COVID-19 pandemic.
Key Points:
- SURREY, British Columbia, Nov. 01, 2022 (GLOBE NEWSWIRE) -- A clinical research study has shown that facial topical cream promotes facemask tolerability and compliance during the COVID-19 pandemic.
- The reputable research was led and authored by Dr. Olu Bamgbade at the Salem Pain Clinic in Surrey, British Columbia, Canada.
- Dr. Bamgbade is the director of the Salem Pain Clinic, a specialist pain clinic and research centre( https://salempainclinic.net/ ).
- People who experience facial redness from facemasks should treat their skin with topical hydrocortisone or diphenhydramine cream," advised Dr. Bamgbade.